Clinical trials: Wearable Monitoring
COVID-19 Respiratory Infection, Respiratory Syncytial Virus Infections
Infection Watch Study
This study will reach out to patients who have undergone diagnostic testing for the following respiratory illnesses from January 1st, 2018 to July 9th, 2023: COVID-19, Influenza, Rhinovirus, and Respiratory Syncytial Virus.
- Conditions
- COVID-19 Respiratory Infection, Respiratory Syncytial Virus Infections, Rhinoviral Infections, Influenza Viral Infections
- Trial name
- NCT04623047
- Where
- United States
- Volunteers
- 10,034 people, healthy volunteers welcome
- Sponsor
- Duke University
COVID-19
Clinical Decision Support System Based on Non-invasive Tele-monitoring of COVID-19 Patients
The aim of the study is to provide clinical decision support to healthcare professionals using a wearable for non-invasive multimodal monitoring, allowing early detection of disease progression to severe forms, as well as the…
- Trial name
- SOY+ (NCT04802018)
- Testing
- Clinical decision support system based on non-invasive multimodal monitoring
- Where
- Spain
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- Increase-Tech
Spinal Cord Injuries (SCI), Neurogenic Lower Urinary Tract Dysfunction
Radio-frequency (RF) Bladder Monitor
The goal of this pilot feasibility study is to evaluate a wearable microwave (MW)-based bladder monitoring system in adult volunteers and those with spinal cord injury (SCI) who use self-catheterization for bladder management.
- Conditions
- Spinal Cord Injuries (SCI), Neurogenic Lower Urinary Tract Dysfunction, Neurogenic Bladder (NB)
- Trial name
- NCT07639541
- Testing
- Wearable microwave Bladder Monitoring System
- Where
- Canada
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
Heart Failure, Pulmonary Arterial Hypertension
Non-invasive Pulmonary Artery Prediction
Cardiac remote monitoring devices have expanded our ability to track physiological changes used in the diagnosis and management of patients with cardiac disease.
- Trial name
- ADOPTS (NCT05622695)
- Testing
- catheterization
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Silverleaf Medical Sciences INC
Anxiety Disorders, Alcohol Use Disorder
Monitoring Telemedicine Platform in Patients With Anxiety Symptoms and Alcohol Use Disorder
The objective of this study is to analyze the physiological patterns of two groups of patients, one control and one with anxiety disorder and alcoholic abuse disorder using sensor data from mobile devices and wearables.
- Conditions
- Anxiety Disorders, Alcohol Use Disorder, Depressive Disorder
- Trial name
- REMOTE (NCT03991650)
- Testing
- Monitoring with a device
- Where
- Spain
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- humanITcare
Spine Disease
Wearable Flexible Sensors for Spinal Motion Monitoring
With the deepening of societal aging, degenerative spinal diseases have become increasingly prevalent in China and are one of the leading causes of disability among middle-aged and elderly populations.
- Trial name
- NCT06974721
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Peking University Third Hospital
Heart Failure
Pilot Study of the QI Device for Monitoring of Patients With Congestive Heart Failure
The present study proposes to utilize a novel, wearable device, QI Device, which has multiple sensors embedded in a "wrist-watch" in order to explore its monitoring capabilities in individuals with congestive heart failure.
- Trial name
- NCT02343523
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- Scripps Translational Science Institute
Blood Glucose, High, Blood Glucose, Low
Calibration and Evaluation of Non-Invasive Wireless Blood Glucose Monitoring
Wrist-worn wearables are used for fitness and health monitoring. This global expansion of wearable technology opens up opportunities for the diagnosis and management of chronic conditions.
- Trial name
- NCT05504096
- Testing
- Actxa BGM Tracker (GLO2), SVT In-Ear Prototype (IEP)
- Where
- Singapore
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- KK Women's and Children's Hospital
Atrial Fibrillation (AF), Paroxysmal Atrial Fibrillation (PAF)
Multi-Centre Based Study Recognition of Atrial Fibrillation With the Corsano CardioWatch 287-2 System
This concerns a multi-center, single-arm, diagnostic accuracy study. In this study, a wristband that monitors heart rythm is assessed in clinical and free living conditions.
- Trial name
- COR-AF (NCT06955273)
- Testing
- Corsano CardioWatch 287-2
- Where
- Netherlands
- Volunteers
- 350 people, healthy volunteers welcome
- Sponsor
- Corsano Health B.V.
Monitoring of Patients Following Surgery
Feasibility And Efficacy Of Continuous In-Hospital Patient Monitoring
The investigators plan to study patients who have had cardiac surgery. Current standard practice is to monitor patients who have had cardiac surgery using wall-mounted monitors whilst they are on the Overnight Intensive Recovery…
- Trial name
- LISTEN (NCT01549717)
- Testing
- Fitting of a wireless telemetry device
- Where
- United Kingdom
- Volunteers
- 300 people
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
Diabetes, Peripheral Neuropathy
Wearable Insoles for Recurrent Diabetic Ulcer Prevention
The primary objective of the study is to demonstrate the clinical advantages of using the Orpyx SI Sensory Insole (SI) system as an adjunct to standard of care in reducing plantar ulceration in high-risk individuals.
- Conditions
- Diabetes, Peripheral Neuropathy, Diabetic Foot Ulcer
- Trial name
- WIREDUP (NCT07674420)
- Testing
- Orpyx Sensory Insole System
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Johns Hopkins University
Atrial Fibrillation (AF)
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
The DESTINATION Study investigates whether anticoagulation therapy is necessary after successful catheter ablation (CA) for atrial fibrillation (AF).
- Trial name
- DESTINATION (NCT06615596)
- Testing
- discontinue anticoagulation therapy, Anticoagulant drugs, Catheter Ablation
- Where
- 12 sites in United States, China
- Volunteers
- 3,160 people
- Sponsor
- China National Center for Cardiovascular Diseases